A detailed history of Great Point Partners LLC transactions in Insmed Inc stock. As of the latest transaction made, Great Point Partners LLC holds 775,585 shares of INSM stock, worth $50 Million. This represents 5.15% of its overall portfolio holdings.

Number of Shares
775,585
Previous 225,912 243.31%
Holding current value
$50 Million
Previous $7 Million 200.54%
% of portfolio
5.15%
Previous 1.48%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$25.72 - $29.94 $14.1 Million - $16.5 Million
549,673 Added 243.31%
775,585 $21 Million
Q4 2023

Feb 14, 2024

SELL
$23.42 - $31.74 $3.96 Million - $5.36 Million
-168,960 Reduced 42.79%
225,912 $7 Million
Q3 2023

Nov 14, 2023

BUY
$19.86 - $26.93 $7.84 Million - $10.6 Million
394,872 New
394,872 $9.97 Million
Q1 2020

May 15, 2020

SELL
$13.63 - $33.98 $1.33 Million - $3.31 Million
-97,359 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$16.12 - $24.98 $1.57 Million - $2.43 Million
97,359 New
97,359 $2.33 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $8.74B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.